SPL-410
SPL-410 is an orally active, highly potent and selective hydroxyethylamine based SPPL2a (Signal Peptide Peptidase Like 2a) inhibitor, with an IC50 of 9 nM[1].
Product Specifications
CAS Number
[2351886-00-3]
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/spl-410.html
Concentration
10mM
Purity
99.38
Solubility
DMSO : 190 mg/mL (ultrasonic)
Smiles
N[C@H]([C@@H](O)CN(C1CCC1)S(C2=CC=C(C(C)(C)C)C=C2)(=O)=O)C3=CC=C(OC(F)(F)F)C=C3
Molecular Formula
C24H31F3N2O4S
Molecular Weight
500.57
References & Citations
[1]Velcicky J, et al. Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors. ACS Med Chem Lett. 2019 May 23;10 (6) :887-892.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CTGF (Connective Tissue Growth Factor, Hypertrophic Chondrocyte-specific Protein 24, Insulin-like Growth Factor-binding Protein 8, IGF-binding Protein 8, IGFBP-8, IBP-8, CCN Family Member 2, CCN2, HCS24, IGFBP8)
